We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-3.73%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$279M
AUM Growth
+$25M
Cap. Flow
-$440M
Cap. Flow %
-158.03%
Top 10 Hldgs %
59.15%
Holding
68
New
18
Increased
13
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
RCM
R1 RCM Inc. Common Stock
RCM
+$18.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$14.2M
3
HCA icon
HCA Healthcare
HCA
+$13.7M
4
CRL icon
Charles River Laboratories
CRL
+$10.1M
5
BMY icon
Bristol-Myers Squibb
BMY
+$9.66M

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$14.5M
2
IRTC icon
iRhythm Holdings
IRTC
+$8.18M
3
AVDR
Avedro, Inc Common Stock
AVDR
+$7.03M
4
HUM icon
Humana
HUM
+$6.7M
5
EHC icon
Encompass Health
EHC
+$6.5M

Sector Composition

Rank Sector Weight
1 Healthcare 76.68%
2 Industrials 7.62%
3 Technology 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBIO
51
Crescent Biopharma
CBIO
$552M
– –
-423
Closed -$504K
IRTC icon
52
iRhythm Holdings
IRTC
$4.1B
– –
-103,448
Closed -$8.18M
MD icon
53
Pediatrix Medical
MD
$2.16B
– –
-39,401
Closed -$994K
SGRY icon
54
Surgery Partners
SGRY
$2.1B
– –
-287,720
Closed -$2.34M
SIBN icon
55
SI-BONE Inc
SIBN
$818M
– –
-65,216
Closed -$1.33M
SRPT icon
56
Sarepta Therapeutics
SRPT
$1.68B
– –
-3,753
Closed -$570K
TNDM icon
57
Tandem Diabetes Care
TNDM
$1.38B
– –
-19,579
Closed -$1.26M
XRAY icon
58
Dentsply Sirona
XRAY
$2.83B
– –
-82,813
Closed -$4.83M
NVRO
59
DELISTED
NEVRO CORP.
NVRO
– –
-63,394
Closed -$4.11M
GRTS
60
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-143,752
Closed -$1.6M
MRNS
61
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-90,547
Closed -$1.5M
RVLP
62
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-514,239
Closed -$1.95M
VCRA
63
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-203,000
Closed -$6.48M
TBIO
64
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-38,772
Closed -$490K
AVDR
65
DELISTED
Avedro, Inc Common Stock
AVDR
– –
-357,942
Closed -$7.03M
1 2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Endurant Capital Management held 68 positions worth $279M, up 9.9% from $254M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Endurant Capital Management withdrew a net $440M in Q3 2019, closing 19 positions and reducing 17 holdings. Its most notable exit was iRhythm Holdings, an estimated $8.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 77% a quarter earlier, followed by Industrials and Technology.

Against the trend, Endurant Capital Management opened a new position in Johnson & Johnson worth $13.9M.

  • Endurant Capital Management's largest Q3 2019 buy was Johnson & Johnson: 107,413 shares worth $13.9M.
  • Endurant Capital Management added most to R1 RCM Inc. Common Stock in Q3 2019, an estimated $18.3M increase.
  • Endurant Capital Management's biggest Q3 2019 reduction was Takeda Pharmaceutical, cutting an estimated $14.5M.
  • Endurant Capital Management fully exited iRhythm Holdings in Q3 2019, selling an estimated $8.18M.
  • Endurant Capital Management's ten largest holdings make up 59% of its $279M portfolio in Q3 2019.
  • Endurant Capital Management opened 18 new positions and closed 19 in Q3 2019.
  • Endurant Capital Management's portfolio value rose 9.9% quarter-over-quarter to $279M.

Based on Endurant Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.